Medable Wins 2024 Prix Galien UK Award for Best Digital Health Solution

This recognition is the second consecutive Prix Galien award for Medable’s evidence generation platform

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology provider for modern clinical trials, today announced that its evidence generation platform was awarded “Best Digital Health Solution” from a field of 17 nominees at the Prix Galien UK Forum in London. This marks the second time Medable has won the Best Digital Health Solution award, first taking home the honor in 2023 at the Prix Galien US ceremony.

Medable’s platform is currently trusted by 14 of the top 20 world’s largest pharmaceutical companies and 9 of the top 10 largest Contract Research Organizations (CROs). Medable’s customers have achieved impressive results with decentralized and hybrid trials – including 200 percent faster enrollment and 50 percent cost reductions.

“This recognition is a tremendous honor and a testament to our steadfast dedication to revolutionizing drug development,” said Medable CEO and co-founder Dr. Michelle Longmire. “Congratulations to all the nominees. We look forward to collaborating with industry leaders and partners to accelerate the journey from scientific discovery to real-world impact and drive progress forward.”

The Prix Galien Awards are organized by The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences.

“This year's winners and their pioneering solutions are driving significant advancements in patient care. These visionary leaders are paving the way for a healthier future, and it is an honour to celebrate their remarkable achievements,” said Bruno Cohen, Chairman of The Galien Foundation. “With profound gratitude, we acknowledge their tireless pursuit of knowledge and the enduring legacy they are forging for generations to come.”

About The Galien Foundation

The Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives.

The Foundation oversees and directs activities in the US for the Prix Galien, an international awards program dedicated to progress through innovative medicines development, with chapters in 14 countries and Africa. The Prix Galien was created in 1970 by Roland Mehl in honor of Galien, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

About Medable

Medable is on a mission to get effective therapies to patients faster by transforming clinical drug development with disruptive technologies. The company’s digital platform streamlines design, recruitment, retention, and data quality for decentralized trials, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution. Medable connects patients, sites, and clinical trial teams to improve patient access, experience, and outcomes. Medable’s software has been named a Leader in the industry by both Everest Group and IDC. Medable is a privately held, venture-backed company headquartered in Palo Alto, California.